• A
• B
• C
• D
• E
• F
• G
• H
• I
• K
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

C1inhibitor (human) (Cinryze®)

Cabazitaxel (Jevtana®)

Cabotegravir (Vocabria®) in combination with rilpivirine (Rekambys®). HTA ID: 21026

Cabozantinib (Cabometyx®)

Cabozantinib (Cabometyx®) in combination with nivolumab (Opdivo®) for 1L RCC. HTA ID: 22018

Cabozantinib (Cometriq®)

Calcipotriol and betamethasone dipropionate cutaneous foam (Enstilar ®)

Camellia sinensis, folium (green tea leaf) (Catephen 10%®)

Canagliflozin (Invokana®)

Cannabidiol (Epidyolex®) for the treatment of Dravet Syndrome. HTA ID: 20004